Clark Eliana
Intellia Therapeutics, Inc. · EVP
Clark Eliana is listed in filings as EVP at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 3, 2026, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jul 3, 2024 to Mar 3, 2026. Reported amounts are shown as $8.4K to $87.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $88k9.5k shares | SellJan 5, 2026 | $9.21 | $13.04 | |
| $10k1k shares | SellJul 1, 2025 | $9.82 | $13.04 | |
| $6.1k679 shares | SellMar 4, 2025 | $8.99 | $13.04 | |
| $90k7.4k shares | SellJan 3, 2025 | $12.18 | $13.04 | |
| $6.7k556 shares | SellJan 2, 2025 | $12.03 | $13.04 | |
| $9.3k405 shares | SellJul 1, 2024 | $22.93 | $13.04 |